UPMC Children's Hospital of Pittsburgh
Locations
Transplant Summary
Overview
The CHP Blood and Marrow Transplantation and Cellular Therapies Program has a dedicated team of clinicians, researchers and support staff with a state of the art Stem Cell Lab and GMP Facility. We utilize cord blood, peripheral blood and bone marrow with special processing methods to reduce severe graft-versus-host disease. We perform over 40 autologous and allogeneic stem cell transplants yearly for pediatric as well as select adult patients enrolled on institutional clinical trials. The inpatient unit consists of 16 Hepa filtered beds and an isolation playroom. The newly renovated outpatient clinic is fully equipped with family centered playrooms, private clinic rooms and an on-site laboratory. We take pride in providing leading transplant care with our overall survival rate above the national average.This center has been performing allogeneic transplants since 1991 and has been an NMDP transplant center since January 1992.
Attending physicians
Adult - Craig Byersdorfer, Pauline Horvei, Archana Ramgopal, Paul Szabolcs, Randy Windreich
Pediatric - Craig Byersdorfer, Pauline Horvei, Archana Ramgopal, Paul Szabolcs, Randy WindreichTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Pediatric onlyOther programs and services
Child Life: A Masters-prepared Child Life Specialist is assigned to each transplant unit to work with children pre- and post-transplant to help them understand their transplant and cope with lengthy hospitalizations. Following discharge, the Child Life Department is often able to provide free passes to families for local activities such as museums, Pittsburgh Zoo and baseball games. This helps the child to return to family and community activities and helps encourage parents to increase activity as their child recuperates.
School: School-age children are referred for tutoring as soon as possible. This is organized through the Allegheny County Public School system. Older children meet in a classroom within CHP. Younger children or those who cannot leave their room have bedside instruction. Assignments from the home school are used, when possible, to try and keep the child with his class. Tutoring is also provided at the Ronald McDonald House or Family House.
Occupational/Speech/Physical Therapies: The Transplant Department implements these services as soon as possible and continues them outpatient until the family returns home. This supports patients during transplant and helps recover their potential post-transplant. Specialized therapy is available to those with developmental delays, oral aversion and speech problems.
Social Service: A social worker completes an assessment of patient and family functioning and provides psychosocial care and support for transplant candidates and families. The family is guided to financial assistance programs and support groups. Families are advised about fundraising and applying for assistance to support expenses related to a local residence, childcare and travel expenses. Pastoral care is available.
Local Residence: Families must often stay in the Pittsburgh area for some time depending on the type of transplant and complications. There is a Ronald McDonald House on the CHP campus and a Family House nearby. Housing is arranged through Social Work.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 63 patients.The actual 1-year survival of these patients is 87.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.8% and 91.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
65
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow8PBSC2Cord blood0Total10Marrow9PBSC8Cord blood17Total34Marrow17PBSC10Cord blood17Total44MarrowBoth marrow & PBSC 21PBSC—Cord blood—Total21MarrowBoth marrow & PBSC 48PBSC—Cord blood17Total65All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181019-44045-64065+0Total10Unrelated 0-183119-44445-64065+0Total35Autologous 0-181919-44245-64065+0Total21Total 0-186019-44645-64065+0Total66Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
UPMC Children's Hospital of Pittsburgh
4401 Penn Avenue Pittsburgh, PA 15224 Phone:412-692-5055 Physician Referrals:412-692-6740 For more information about this program: http://www.chp.edu/our-services/blood-marrow-transplant-cellular-therapies (Opens in a new tab)Staff
Program Director:Randy Windreich, MDPatient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 1 year after transplant.
- Patients who were transplanted as a child at this center with no upper age limit
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program
- Will accept adult patients who were transplanted as a child at another center